Top Markets
Coin of the day
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Hisse Senetlerindeki Sıralama #38792
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Hisse Fiyatı
$0.099
Piyasa Değeri
$801.50K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-34.44%
Ülke
US
Ticaret ZyVersa Therapeutics, Inc. (ZVSA)

Kategori

ZyVersa Therapeutics, Inc. (ZVSA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.11 - 2026-08-01

Gün sonu en düşük fiyat: $3.45K - 2022-02-01
ZyVersa Therapeutics, Inc. için hisse fiyatı geçmişi: 2022 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 21.33%
2025 -87.48%
2024 -90.24%
2023 -99.49%
2022 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$508.06 30.17%
US
$849.76 30.25%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE